Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription 14.09.2026 1 Biochem Biophys Res Commun 1 BMC Cancer 1 Br J Dermatol 2 Eur J Dermatol 3 Int J Cancer 3 J Am Acad Dermatol 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biochem Biophys Res Commun

1. CHEN M, Wang C, Chen Z, Xu G, et al
   Characteristics of plasma-activated water and its effect on apoptosis of malignant melanoma cells.
   Biochem Biophys Res Commun. 2026;835:154560.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. DOU B, Wu R, Ma X, Hu C, et al
   Preparation, characterization and anticancer applications of HAase from Pedobacter heparinus.
   BMC Cancer. 2026;26:1086.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

3. LU S, Micevic G, McGrath JA
   Personalised mRNA Therapy Comes of Age in Melanoma.
   Br J Dermatol. 2026 Sep 8:ljag378. doi: 10.1093.
   PubMed        
   
   

   
   Eur J Dermatol

4. SANCHEZ-ARJONA M, Ramos-Caballo M, Alfageme-Roldan F, Najera-Botello L, et al
   Ultrasound assessment of suspected pseudoprogression during neoadjuvant immunotherapy for desmoplastic melanoma of the scalp.
   Eur J Dermatol. 2026;36:390-392.
   PubMed        
   
   
5. GAMBICHLER T, Ruhe C, Weyer-Fahlbusch SS, Susok L, et al
   Baseline C-reactive protein independently predicts treatment response and survival in metastatic melanoma patients receiving first-line immune checkpoint inhibitors.
   Eur J Dermatol. 2026;36:384-386.
   PubMed        
   
   

   
   Int J Cancer

6. LIU CG, Yang J, Luo R, Sun R, et al
   Comments on "Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma".
   Int J Cancer. 2026 Sep 11. doi: 10.1002/ijc.70702.
   PubMed        
   
   
7. KOFFKA F, Kornowski J, Laakmann E, Schmalfeldt B, et al
   Incidence and Predictors of Immune-Related Hypothyroidism Under Pembrolizumab Across Gynecologic Malignancies and Melanoma: A Real-World Cohort Study.
   Int J Cancer. 2026 Sep 10. doi: 10.1002/ijc.70735.
   PubMed         Abstract available
   
   
8. BLOEM M, de Meza MM, Boreel CDM, Aarts MJB, et al
   Early Cessation of Adjuvant Anti-PD-1 Therapy in Stage III and IV Melanoma.
   Int J Cancer. 2026 Sep 9. doi: 10.1002/ijc.70738.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

9. WANG X
   Comment on Wei et al.'s "Association of primary tumor location with all-cause and cancer-specific mortality in cutaneous malignant melanoma patients".
   J Am Acad Dermatol. 2026 Sep 12:S0190-9622(26)03528.
   PubMed        
   
   
10. BEAGLES E, Khattab S, Burke OM, Mahajan A, et al
    Refining the Definition of Acral Melanoma: Histologic and Anatomic Considerations.
    J Am Acad Dermatol. 2026 Sep 9:S0190-9622(26)03441.
    PubMed        
    
    
11. HUHMANN LB, Hwang JC, Lu C, Perez D, et al
    Prior Keratinocyte Carcinoma as a Risk Factor for Mucosal Melanoma: A Multi-Institutional Retrospective Case-Control Study of Veterans and Civilians in the Veterans Health Administration and Mass General Brigham.
    J Am Acad Dermatol. 2026 Sep 9:S0190-9622(26)03467.
    PubMed        
    
    

    
    PLoS One

12. LIU Q, Ma J, Yang H, Liu N, et al
    Burden of malignant melanoma among the elderly population in East Asia from 1990 to 2023 and machine learning projection to 2040.
    PLoS One. 2026;21:e0357767.
    PubMed         Abstract available
    
    
13. WU C, Yang Y, Wang C, Shen Y, et al
    Clinicopathological characteristics and prognosis of melanoma: A retrospective cohort study in Xinjiang, China.
    PLoS One. 2026;21:e0357383.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

14. KUANG SH, Abrenica AG, Kar N, Logue JS, et al
    Targeting cholesterol-dependent Piezo1 activation impairs amoeboid migration in melanoma cells.
    Proc Natl Acad Sci U S A. 2026;123:e2607369123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum